Fresenius Medical Care Ventures

Fresenius Medical Care is a global leader in providing products and services for individuals with renal diseases, managing the care of approximately 4.1 million patients worldwide. The company operates over 4,000 dialysis clinics and offers an extensive range of products for in-center and home dialysis, including dialysis machines and related disposables. Strategically, Fresenius is focusing on three core areas: the renal care continuum, critical care solutions, and complementary assets. This approach involves new renal care models, such as personalized dialysis and home care, value-based care, and advancing treatments for chronic kidney disease (CKD) and transplantation. The company is committed to enhancing healthcare for chronically and critically ill patients, aiming to offer high-quality, sustainable solutions at reliable costs. Fresenius Medical Care is also in the midst of a significant portfolio optimization program. In 2023, the company executed several strategic divestments to focus on businesses with the best strategic fit and greatest scale, while also improving its leverage ratio by allocating proceeds from these divestments​.